Management of bowel obstruction in advanced and terminal cancer patients

C. Ripamonti, F. De Conno, V. Ventafridda, B. Rossi, M. J. Baines

Research output: Contribution to journalArticle

Abstract

Background: Bowel obstruction is a common and distressing outcome in patients with abdominal or pelvic cancer. Patients and methods: Patients may develop bowel obstruction at any time in their clinical history, with an incidence ranging from 5.5% to 42% in ovarian carcinoma and from 10% to 28.4% in colorectal cancer. The causes of the obstruction may be benign postoperative adhesions, a focal malignant or benign deposit, relapse or diffuse carcinomatosis. The symptoms which are almost always present are intestinal colic (reported in 72%-76% of patients), abdominal pain due to distension, hepatomegaly or tumor masses (in 92% of patients) and vomiting (68%-100%) of cases. Conclusion: While surgery must remain the primary treatment for malignant obstruction, it is now recognised that there is a group of patients with advanced disease or poor general condition who are unfit for surgery and require alternative management to relieve distressing symptoms. A number of treatment options are now available for the patient with advanced cancer who develops intestinal obstruction. In this review of the literature, the indications for surgery will be examined, the use of nasogastric tube and percutaneous gastrostomy evaluated and the place of drugs for symptom control described.

Original languageEnglish
Pages (from-to)15-21
Number of pages7
JournalAnnals of Oncology
Volume4
Issue number1
Publication statusPublished - 1993

    Fingerprint

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Public Health, Environmental and Occupational Health
  • Neuropsychology and Physiological Psychology
  • Hematology

Cite this

Ripamonti, C., De Conno, F., Ventafridda, V., Rossi, B., & Baines, M. J. (1993). Management of bowel obstruction in advanced and terminal cancer patients. Annals of Oncology, 4(1), 15-21.